Neo-Vinci introduces the eQuest platform

Neo-Vinci introduces the eQuest platform, which serves to educate and educate a selected audience, along with parallel analysis of epidemiological data.

Neo-Vinci, a marketing agency focusing on pharma marketing, is launching a new, innovative product on the market. This is the eQuest platform. This platform will allow its users to enrich their knowledge and to collect and use in parallel information that would not be otherwise available to them.

eQuest

The provision of key data in the medical and pharmaceutical sector should be more than just a response to the needs of the sector. Neo-Vinci is an agency that wanted to find a way not only to meet these needs, but also to systematically improve the quality of healthcare services.

Using its many years of experience in the medical and pharmaceutical industry, Neo-Vinci has created the eQuest platform. It is a system that serves to improve competences through systematic delivery of knowledge along with simultaneous analysis of preferences of selected target groups. It also makes it possible to monitor the progress of the learning process that has begun. One of its most interesting features is that it allows you to easily create an educational channel for a selected target group.

The eQuest platform, supported by Ideo Global accelerator, is one of 121 startups that took part in the UP Scale program.

Neo-Vinci

The Neo-Vinci marketing agency delivers relevant products related to the pharmaceutical and medical sectors. The Agency's goal is to raise awareness of its clients. It also has a positive impact on the quality of health and life not only of eQuest users but also of all those who use the services of Neo-Vinci customers.

"Neo-Vinci, as an agency with extensive experience in creating solutions for the medical and pharmaceutical industry, has built an effective platform to meet the needs of each of the parties involved in the healthcare sector. eQUEST is a comprehensive solution that allows to reach a selected group of recipients, to bind them together over a longer period of time and to obtain such important statistical and epidemiological data on an ongoing basis. We are proud that not only pharmaceutical companies, but also scientific societies and universities are becoming more and more popular among our customers. We are convinced that 2018 and the following years will bring new opportunities for the implementation of our solutions, thus creating even greater potential for the development of the eQUEST platform and related products. "Arthur Konefał, CEO of Neo-Vinci...

Neo-Vinci is currently involved in a number of projects on a national scale, which will use the agency's proprietary solutions.